Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant for OSA with Low Arousal Threshold
NCT05763329Phase 2Completed
- Sponsor
- Chulalongkorn University
- Start
- Feb 2023
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lemborexant in obstructive sleep apnea (OSA), sponsored by Chulalongkorn University. Started Feb 2023; status: completed.
02
Drugs
lemborexant
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT05763329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05763329.